The Ikena Approach
We develop differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Our ever-growing depth of institutional knowledge and breadth of tools enable us to efficiently develop the right drug using the right modality for the right patient.
We are advancing a diverse pipeline of novel biomarker-driven targeted cancer therapies. Our programs are built on robust translational research and are optimized for specific patient populations with high unmet needs.
Join Our Team
Interested in learning more about Ikena?